Tumor mutational burden is a determinant of immune-mediated survival in breast cancer

Mounting evidence supports a role for the immune system in breast cancer outcomes. The ability to distinguish highly immunogenic tumors susceptible to anti-tumor immunity from weakly immunogenic or inherently immune-resistant tumors would guide development of therapeutic strategies in breast cancer....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Thomas, Alexandra, Routh, Eric D., Pullikuth, Ashok, Jin, Guangxu, Su, Jing, Chou, Jeff W., Hoadley, Katherine A., Print, Cristin, Knowlton, Nick, Black, Michael A., Demaria, Sandra, Wang, Ena, Bedognetti, Davide, Jones, Wendell D., Mehta, Gaurav A., Gatza, Michael L., Perou, Charles M., Page, David B., Triozzi, Pierre, Miller, Lance D.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207420/
https://ncbi.nlm.nih.gov/pubmed/30386679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1490854
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados